Long-term effects of transdermal estradiol with and without medroxyprogesterone acetate**Supported by a grant from the Ciba Geigy Corporation, Summit, New Jersey, and by grant RR 865 from the United States Public Health Service, Bethesda, Maryland.

Autor: Pang, Samuel C., Greendale, Gail A., Cedars, Marcelle I., Gambone, Joseph C., Lozano, Kathleen, Eggena, Peter, Judd, Howard L.
Zdroj: Fertility and Sterility; January 1993, Vol. 59 Issue: 1 p76-82, 7p
Abstrakt: To study the long-term biological and metabolical effects of estradiol (E2) administered by transdermal therapeutic systems with and without the addition of medroxyprogesterone acetate (MPA).
Databáze: Supplemental Index